Mindray Hepatus 9 Ultrasound Diagnostic System

1

Review clinical trials related to Mindray Hepatus 9 Ultrasound Diagnostic System. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Multicenter Clinical Study on Noninvasive Assessment of Hepatic Steatosis and Fibrosis Using Visual Transient Elastography

Using liver biopsy as the gold standard, this study will conduct visual transient elastography (ViTE) examinations using Mindray Hepatus 9 ultrasound diagnostic system in patients with liver injury to evaluate the diagnostic efficacy of Liver Steatosis Analysis (LiSA) and ViTE for grading hepatic steatosis and fibrosis, and establish corresponding diagnostic thresholds.

Participants needed: 225
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Xinhua Hospital, Shanghai Jiao Tong University School of MedicineUpdated: Nov 24, 2025Locations: 1
Eligibility criteria

Be aged 18-65 years. [+2]

Acute viral hepatitis. [+4]